The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Uric acid‐dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids
Open accessAbstract
Reduced AMP kinase (AMPK) activity has been shown to play a key deleterious role in increased hepatic gluconeogenesis in diabetes, but the mechanism whereby this occurs remains unclear. In this article, we document that another AMP‐dependent enzyme, AMP deaminase (AMPD) is activated in the liver of diabetic mice, which parallels with a significant reduction in AMPK activity and a significant increase in intracellular glucose accumulation in human HepG2 cells. AMPD activation is induced by a reduction in intracellular phosphate levels, which is characteristic of insulin resistance and diabetic states. Increased gluconeogenesis is mediated by reduced TORC2 phosphorylation at Ser171 by AMPK in these cells, as well as by the up‐regulation of the rate‐limiting enzymes PEPCK and G6Pc. The mechanism whereby AMPD controls AMPK activation depends on the production of a specific AMP downstream metabolite through AMPD, uric acid. In this regard, humans have higher uric acid levels than most mammals due to a mutation in uricase, the enzyme involved in uric acid degradation in most mammals, that developed during a period of famine in Europe 1.5 X 10 7 yr ago. Here, working with resurrected ancestral uricases obtained from early hominids, we show that their expression on HepG2 cells is enough to blunt gluconeogenesis in parallel with an up‐regulation of AMPK activity. These studies identify a key role AMPD and uric acid in mediating hepatic gluconeogenesis in the diabetic state, via a mechanism involving AMPK down‐regulation and overexpression of PEPCK and G6Pc. The uricase mutation in the Miocene likely provided a survival advantage to help maintain glucose levels under conditions of near starvation, but today likely has a role in the pathogenesis of diabetes.—Cicerchi, C., Li, N., Kratzer, J., Garcia, G., Roncal‐Jimenez, C. A., Tanabe, K., Hunter, B., Rivard, C. J., Sautin, Y. Y., Gaucher, E. A., Johnson, R. J., Lanaspa, M. A. Uric acid‐dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: Evolutionary implications of the uricase loss in hominids. FASEB J. 28, 3339–3350 (2014). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
Petersen, K. F., Dufour, S., & Shulman, G. I. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020233 · Cited by 308 · cited 1×
“Insulin not only stimulates glucose uptake, but also uptake of phosphate and potassium into multiple tissues (25, 26, 34).”
BackgroundLiver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M. (2011) · Diabetes Care · doi:10.2337/dc10-1076 · Cited by 212
Cited by
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
Self-citationJohnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Self-citationUric acid and cardiovascular disease
Ndrepepa, G. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.046 · Cited by 498
Soluble Uric Acid Activates the NLRP3 Inflammasome
Braga, T. T., Forni, M. F., Correa-Costa, M., Ramos, R. N., Barbuto, J. A., Branco, P., Castoldi, A., Hiyane, M. I., Davanso, M. R., Latz, E., et al. (2017) · Scientific Reports · doi:10.1038/srep39884 · Cited by 440
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., Redon, J., Stack, A. G., & Tsioufis, K. P. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.006 · Cited by 435
Self-citationUric acid in metabolic syndrome: From an innocent bystander to a central player
Kanbay, M., Jensen, T., Solak, Y., Le, M., Roncal-Jimenez, C., Rivard, C., Lanaspa, M. A., Nakagawa, T., & Johnson, R. J. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.11.026 · Cited by 419
“Indeed, insulin resistance in models of metabolic syndrome can be improved by lowering serum uric acid [15,16], and uric acid has been shown to block AMP-activated protein kinase and to stimulate gluconeogenesis [3].”
Self-citationUric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review
Sharaf El Din, U. A. A., Salem, M. M., & Abdulazim, D. O. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2016.11.004 · Cited by 417
Fang, Y.-L., Chen, H., Wang, C.-L., & Liang, L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2974 · Cited by 379
Wan, X., Xu, C., Lin, Y., Lu, C., Li, D., Sang, J., He, H., Liu, X., Li, Y., & Yu, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.022 · Cited by 364
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Joosten, L. A. B., Crişan, T. O., Bjornstad, P., & Johnson, R. J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0334-3 · Cited by 319
Self-citationUric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Kimura, Y., Tsukui, D., & Kono, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212394 · Cited by 309
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview
Chen, C., Lü, J.-M., & Yao, Q. (2016) · Medical Science Monitor · doi:10.12659/msm.899852 · Cited by 302
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Copur, S., Demiray, A., & Kanbay, M. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.04.022 · Cited by 287
Uric acid as a modulator of glucose and lipid metabolism
Lima, W. G., Martins-Santos, M. E. S., & Chaves, V. E. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.025 · Cited by 270
A model of the mitochondrial basis of bipolar disorder
Morris, G., Walder, K., McGee, S. L., Dean, O. M., Tye, S. J., Maes, M., & Berk, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.014 · Cited by 162
Are Liquid Sugars Different from Solid Sugar in Their Ability to Cause Metabolic Syndrome?
Sundborn, G., Thornley, S., Merriman, T. R., Lang, B., King, C., Lanaspa, M. A., & Johnson, R. J. (2019) · Obesity · doi:10.1002/oby.22472 · Cited by 103
Self-citationFactors modulating the inflammatory response in acute gouty arthritis
Cleophas, M. C., Crişan, T. O., & Joosten, L. A. B. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000366 · Cited by 62
Pro-Aging Effects of Xanthine Oxidoreductase Products
Battelli, M. G., Bortolotti, M., Bolognesi, A., & Polito, L. (2020) · Antioxidants · doi:10.3390/antiox9090839 · Cited by 38
Metadata
- Authors
- Cicerchi, C., Li, N., Kratzer, J., Garcia, G., Roncal‐Jimenez, C. A., Tanabe, K., Hunter, B., Rivard, C. J., Sautin, Y. Y., Gaucher, E. A., Johnson, R. J., & Lanaspa, M. A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2014-04-22
- Volume
- 28
- Issue
- 8
- Pages
- 3339-3350
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2156896055
- Cited by
- 187
- References
- 4
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.